Search Results 1881-1890 of 24120 for autoimmune hepatitis

  1. Ivosidenib, Nivolumab, and Ipilimumab Combination in Previously Treated Subjects with Nonresectable or Metastatic IDH1-Mutant Cholangiocarcinoma - Mayo Clinic

    ... autoimmune disease. ... autoimmune origin (e.g., Guillain-Barre syndrome, myasthenia gravis). Known immunodeficiency or HIV, hepatitis B, or hepatitis C infection ...

  2. Medical Research & Education - Mayo Clinic News Network

    ... liver disease. Latest stories. Mindfulness may ease menopausal symptoms ... Recruiting Microbes to Fight Autoimmune Diseases. Mayo Clinic Staff. January ...

  3. Paraldehyde (oral route, injection route, rectal route) - Mayo Clinic

    Liver disease—Higher blood levels of paraldehyde may occur, increasing the chance of side effects. Gastroenteritis (stomach flu) or; Stomach ulcer—Paraldehyde ...

  4. Ferric carboxymaltose (intravenous route) - Side effects & uses - Mayo Clinic

    Liver disease—May increase risk to develop iron overload. Back to top. Proper Use. A nurse or other trained health professional will give you this medicine ...

  5. Mayo Clinic Transplant Center - Doctors

    ... liver disease, Portal hypertension, Alcoholic hepatiti...s, Budd-Chiari syndrome, Chronic liver disease, Hepatic encephalopathy, Fontan-associated liver disease.

  6. Emricasan, a Caspase Inhibitor, for Treatment of Subjects With Decompensated NASH Cirrhosis - Mayo Clinic

    Cirrhosis due to NASH with exclusion of other causes of cirrhosis (e.g. chronic viral hepatitis, alcoholic liver disease, etc.) At least one of the ...

  7. Clinical Trials - PR3-AAV Resilient Remission or PRRR

    Infection (blood borne): active hepatitis B or active hepatitis C or a documented history of HIV, hepatitis B, or hepatitis C. - ... - Liver disease: acute or ...

  8. Pramipexole (oral route) - Mayo Clinic

    Pramipexole is used to treat Parkinson disease. It may be used alone or in combination with other medicines (eg, levodopa). Pramipexole is a dopamine agonist ...

  9. A Study to Evaluate the Safety and Effectiveness of IFX-1 in Add-on to Standard of Care in Granulomatosis with Polyangiitis (GPA) and Microscopic Polyangiitis (MPA) - Mayo Clinic

    Any other multisystem autoimmune disease. ... hepatitis B, or hepatitis C. One of the following ... Acute or chronic liver disease. Known ...

  10. Deuruxolitinib (oral route) - Side effects & dosage - Mayo Clinic

    Hepatitis C, history of or; Herpes zoster infection or; Kidney disease or; Liver disease or; Lung or breathing problems or; Stomach or bowel problems (eg, ...